Molly-Maureen Huntsman
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fragile X Syndrome | 10 | 2021 | 74 | 3.470 |
Why?
| Fragile X Mental Retardation Protein | 9 | 2021 | 61 | 1.810 |
Why?
| Neural Inhibition | 8 | 2017 | 152 | 1.640 |
Why?
| Amygdala | 7 | 2021 | 179 | 1.580 |
Why?
| Nerve Net | 5 | 2017 | 228 | 1.090 |
Why?
| Synapses | 6 | 2021 | 336 | 1.030 |
Why?
| Receptors, GABA-A | 6 | 2015 | 88 | 0.970 |
Why?
| Synaptic Transmission | 4 | 2021 | 232 | 0.900 |
Why?
| gamma-Aminobutyric Acid | 5 | 2015 | 151 | 0.710 |
Why?
| Excitatory Postsynaptic Potentials | 2 | 2014 | 101 | 0.700 |
Why?
| Inhibitory Postsynaptic Potentials | 4 | 2015 | 32 | 0.690 |
Why?
| Interneurons | 3 | 2014 | 99 | 0.620 |
Why?
| Action Potentials | 4 | 2014 | 410 | 0.600 |
Why?
| Cerebral Cortex | 3 | 2011 | 386 | 0.590 |
Why?
| Isoxazoles | 4 | 2015 | 56 | 0.570 |
Why?
| Excitatory Amino Acid Antagonists | 2 | 2015 | 89 | 0.500 |
Why?
| Dizocilpine Maleate | 1 | 2014 | 15 | 0.490 |
Why?
| GABA Agonists | 3 | 2015 | 17 | 0.480 |
Why?
| Neuronal Plasticity | 2 | 2012 | 214 | 0.440 |
Why?
| Protein Subunits | 3 | 2014 | 204 | 0.430 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 182 | 0.430 |
Why?
| Homeostasis | 2 | 2013 | 577 | 0.420 |
Why?
| Neurons | 7 | 2017 | 1298 | 0.400 |
Why?
| Cortical Synchronization | 1 | 2011 | 12 | 0.390 |
Why?
| Somatosensory Cortex | 1 | 2011 | 34 | 0.380 |
Why?
| Disease Models, Animal | 9 | 2021 | 3580 | 0.380 |
Why?
| Mice, Knockout | 7 | 2021 | 2604 | 0.370 |
Why?
| Schizophrenia | 1 | 2014 | 418 | 0.360 |
Why?
| Mice | 15 | 2021 | 15052 | 0.350 |
Why?
| Sensory Deprivation | 1 | 2009 | 8 | 0.340 |
Why?
| Animals | 18 | 2021 | 32102 | 0.290 |
Why?
| Intralaminar Thalamic Nuclei | 1 | 2006 | 4 | 0.270 |
Why?
| Patch-Clamp Techniques | 4 | 2015 | 245 | 0.210 |
Why?
| Organ Culture Techniques | 2 | 2013 | 143 | 0.200 |
Why?
| In Vitro Techniques | 4 | 2015 | 1044 | 0.200 |
Why?
| GABA Modulators | 2 | 2015 | 9 | 0.200 |
Why?
| Mice, Inbred C57BL | 6 | 2017 | 4773 | 0.180 |
Why?
| Triazoles | 2 | 2014 | 132 | 0.170 |
Why?
| Mice, Transgenic | 5 | 2017 | 1970 | 0.170 |
Why?
| Hearing | 1 | 2020 | 132 | 0.160 |
Why?
| CLOCK Proteins | 1 | 2017 | 7 | 0.150 |
Why?
| Animals, Newborn | 3 | 2015 | 780 | 0.150 |
Why?
| Gene Expression Regulation | 4 | 2017 | 2353 | 0.150 |
Why?
| Trapezoid Body | 1 | 2017 | 8 | 0.150 |
Why?
| Epilepsies, Partial | 1 | 2017 | 31 | 0.150 |
Why?
| Auditory Pathways | 1 | 2017 | 54 | 0.140 |
Why?
| Membrane Potentials | 2 | 2015 | 251 | 0.140 |
Why?
| Glutamic Acid | 2 | 2017 | 213 | 0.140 |
Why?
| Sound Localization | 1 | 2017 | 64 | 0.140 |
Why?
| Thalamus | 2 | 2008 | 78 | 0.120 |
Why?
| Kv1.1 Potassium Channel | 1 | 2014 | 8 | 0.120 |
Why?
| Status Epilepticus | 1 | 2015 | 33 | 0.120 |
Why?
| Glutamate Decarboxylase | 2 | 2017 | 162 | 0.120 |
Why?
| Parvalbumins | 1 | 2014 | 19 | 0.120 |
Why?
| GABA-A Receptor Agonists | 1 | 2014 | 10 | 0.120 |
Why?
| GABA-A Receptor Antagonists | 1 | 2014 | 15 | 0.120 |
Why?
| Neocortex | 1 | 2014 | 25 | 0.120 |
Why?
| Injections, Subcutaneous | 1 | 2014 | 137 | 0.120 |
Why?
| GABAergic Neurons | 1 | 2014 | 22 | 0.120 |
Why?
| Pyridazines | 1 | 2014 | 46 | 0.120 |
Why?
| Feedback, Physiological | 1 | 2014 | 73 | 0.120 |
Why?
| Phthalazines | 1 | 2014 | 39 | 0.110 |
Why?
| Genes, Reporter | 1 | 2014 | 257 | 0.110 |
Why?
| Luminescent Proteins | 1 | 2014 | 169 | 0.110 |
Why?
| Receptors, Cannabinoid | 1 | 2012 | 14 | 0.100 |
Why?
| Receptors, Glutamate | 1 | 2012 | 19 | 0.100 |
Why?
| Male | 11 | 2017 | 55949 | 0.100 |
Why?
| Amino Acid Transport System X-AG | 1 | 2011 | 3 | 0.100 |
Why?
| STAT Transcription Factors | 1 | 2011 | 14 | 0.100 |
Why?
| Janus Kinases | 1 | 2011 | 13 | 0.100 |
Why?
| Evoked Potentials | 2 | 2010 | 110 | 0.100 |
Why?
| Methoxyhydroxyphenylglycol | 1 | 2011 | 12 | 0.100 |
Why?
| Somatostatin | 1 | 2011 | 53 | 0.100 |
Why?
| Pyramidal Cells | 1 | 2011 | 51 | 0.100 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2011 | 35 | 0.100 |
Why?
| Hippocampus | 2 | 2015 | 709 | 0.090 |
Why?
| Mice, Inbred Strains | 1 | 2011 | 399 | 0.090 |
Why?
| Astrocytes | 1 | 2011 | 163 | 0.090 |
Why?
| Receptors, GABA | 1 | 2009 | 9 | 0.090 |
Why?
| Vibrissae | 1 | 2009 | 11 | 0.080 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 374 | 0.080 |
Why?
| Bacterial Proteins | 1 | 2014 | 739 | 0.080 |
Why?
| Stem Cell Niche | 1 | 2009 | 43 | 0.080 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2008 | 130 | 0.080 |
Why?
| Models, Neurological | 1 | 2009 | 213 | 0.070 |
Why?
| Electric Stimulation | 1 | 2008 | 263 | 0.070 |
Why?
| Clonazepam | 1 | 2006 | 5 | 0.070 |
Why?
| Lysine | 1 | 2008 | 245 | 0.070 |
Why?
| Rats, Sprague-Dawley | 2 | 2015 | 2262 | 0.070 |
Why?
| Brain | 1 | 2017 | 2370 | 0.070 |
Why?
| Cell Differentiation | 1 | 2013 | 1700 | 0.070 |
Why?
| Kinetics | 1 | 2009 | 1569 | 0.070 |
Why?
| Hypoxia | 1 | 2011 | 937 | 0.060 |
Why?
| Electrophysiology | 1 | 2006 | 202 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2009 | 465 | 0.060 |
Why?
| Stem Cells | 1 | 2009 | 546 | 0.060 |
Why?
| Signal Transduction | 2 | 2014 | 4541 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 930 | 0.060 |
Why?
| Phenotype | 1 | 2011 | 2829 | 0.060 |
Why?
| Desoxycorticosterone | 1 | 2003 | 2 | 0.060 |
Why?
| Rats | 2 | 2015 | 5034 | 0.050 |
Why?
| Female | 6 | 2017 | 59913 | 0.040 |
Why?
| RNA, Messenger | 1 | 2006 | 2574 | 0.040 |
Why?
| Acoustic Stimulation | 1 | 2020 | 313 | 0.040 |
Why?
| Glycine Plasma Membrane Transport Proteins | 1 | 2017 | 7 | 0.040 |
Why?
| Vesicular Glutamate Transport Protein 2 | 1 | 2017 | 12 | 0.040 |
Why?
| Cells, Cultured | 2 | 2017 | 3914 | 0.040 |
Why?
| Glycine | 1 | 2017 | 156 | 0.030 |
Why?
| GABA Agents | 1 | 2015 | 3 | 0.030 |
Why?
| Heterocyclic Compounds, 2-Ring | 1 | 2015 | 5 | 0.030 |
Why?
| Pregnanolone | 1 | 2015 | 21 | 0.030 |
Why?
| Cricetulus | 1 | 2015 | 99 | 0.030 |
Why?
| CHO Cells | 1 | 2015 | 140 | 0.030 |
Why?
| Muscarinic Agonists | 1 | 2015 | 10 | 0.030 |
Why?
| Biotinylation | 1 | 2015 | 29 | 0.030 |
Why?
| Pilocarpine | 1 | 2015 | 8 | 0.030 |
Why?
| Valine | 1 | 2015 | 74 | 0.030 |
Why?
| Quinoxalines | 1 | 2015 | 61 | 0.030 |
Why?
| Transfection | 1 | 2015 | 866 | 0.030 |
Why?
| Humans | 3 | 2017 | 115587 | 0.030 |
Why?
| Tyrphostins | 1 | 2011 | 14 | 0.030 |
Why?
| Tritium | 1 | 2011 | 69 | 0.030 |
Why?
| Nestin | 1 | 2011 | 17 | 0.020 |
Why?
| Bromodeoxyuridine | 1 | 2011 | 73 | 0.020 |
Why?
| Gliosis | 1 | 2011 | 30 | 0.020 |
Why?
| Intermediate Filament Proteins | 1 | 2011 | 66 | 0.020 |
Why?
| Aspartic Acid | 1 | 2011 | 79 | 0.020 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2011 | 79 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2015 | 1870 | 0.020 |
Why?
| Cell Count | 1 | 2011 | 305 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 377 | 0.020 |
Why?
| Preoptic Area | 1 | 2009 | 6 | 0.020 |
Why?
| Lac Operon | 1 | 2009 | 46 | 0.020 |
Why?
| Gene Knock-In Techniques | 1 | 2009 | 47 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2009 | 271 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2011 | 757 | 0.020 |
Why?
| Integrases | 1 | 2009 | 117 | 0.020 |
Why?
| Nerve Tissue Proteins | 1 | 2011 | 535 | 0.020 |
Why?
| Prospective Studies | 1 | 2017 | 6264 | 0.020 |
Why?
| Age Factors | 1 | 2011 | 2907 | 0.010 |
Why?
| Cell Movement | 1 | 2009 | 867 | 0.010 |
Why?
| Pregnenolone | 1 | 2003 | 3 | 0.010 |
Why?
| Anesthetics | 1 | 2003 | 57 | 0.010 |
Why?
| Neural Pathways | 1 | 2003 | 260 | 0.010 |
Why?
| Pregnancy | 1 | 2009 | 5548 | 0.010 |
Why?
|
|
Huntsman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|